熱門資訊> 正文
KalVista Pharmaceuticals任命Brian Piekos为财务主管
2024-09-10 18:35
- KalVista Pharmaceuticals (NASDAQ:KALV) said it has appointed Brian Piekos as its finance chief.
- Piekos has over 25 years of experience and most recently served as the CFO of Elicio Therapeutics.
More on KalVista Pharmaceticals
- KalVista Pharmaceuticals: Looking To Be A Major Player In HAE
- Bullish On KalVista Pharmaceuticals: Sebetralstat Nears Approval, Aiming For 2025 Launch
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。